Trials / Completed
CompletedNCT01597752
Biological Standardization of Blomia Tropicalis Allergen Extract
Biological Standardization of Blomia Tropicalis Allergen Extract to Determine the Biological Activity in Histamine Equivalent Prick (HEP) Units
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Laboratorios Leti, S.L. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine the biologic activity of a Blomia tropicalis allergen extract in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).
Detailed description
This is an open, unblinded and non-randomized biological assay. The study design is a slight modification of the recommendations proposed by the Nordic Guidelines. Four concentrations of Blomia tropicalis allergen extract, together with a positive and negative control, using 10 mg/ml histamine dihydrochloride solution and a glycerinated phenol saline solution, respectively, will be tested in every patient in duplicate on the volar surface of the forearm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Four different concentrations of Blomia tropicalis allergen extract, positive control and negative control | Four concentrations of Blomia tropicalis allergen extract, together with a positive and negative control will be tested in every patient in duplicate on the volar surface of the forearm. |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2012-05-14
- Last updated
- 2012-11-30
Locations
2 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01597752. Inclusion in this directory is not an endorsement.